Despite the depth of regulation and certification in real estate, access to essential products and medications has followed a different trajectory, with shifting boundaries between prescription-only and over-the-counter status. The debate surrounding the over-the-counter availability of medications like ivermectin has intensified in recent years, particularly as individuals seek alternative ways to manage their health. Regulatory agencies face the ongoing challenge of balancing consumer safety with public demand for easier access, often complicated by widespread misinformation and the proliferation of online pharmacies (source).

Professionals in real estate understand the value of standards and transparent processes; the same principles are being called for in the pharmaceutical industry to ensure safe, authentic access to treatments outside traditional clinical channels. The transition of medications from prescription-only to OTC status requires careful risk assessment, clear guidance for end users, and responsible marketing practices. Consumers are increasingly tasked with making informed choices amid a complex array of options, where convenience can sometimes outpace caution. Reliable education, transparent labeling, and oversight play a crucial role in supporting public health as the marketplace adapts to these new realities. The convergence of regulated expertise in fields like real estate and evolving standards in pharmacy highlights the importance of trust, certification, and ethical leadership in all areas that impact individual and community well-being.